» Articles » PMID: 20043006

Familial Risk for Mood Disorder and the Personality Risk Factor, Neuroticism, Interact in Their Association with Frontolimbic Serotonin 2A Receptor Binding

Overview
Date 2010 Jan 1
PMID 20043006
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Life stress is a robust risk factor for later development of mood disorders, particularly for individuals at familial risk. Likewise, scoring high on the personality trait neuroticism is associated with an increased risk for mood disorders. Neuroticism partly reflects stress vulnerability and is positively correlated to frontolimbic serotonin 2A (5-HT(2A)) receptor binding. Here, we investigate whether neuroticism interacts with familial risk in relation to frontolimbic 5-HT(2A) receptor binding. Twenty-one healthy twins with a co-twin history of mood disorder and 16 healthy twins without a co-twin history of mood disorder were included. They answered self-report personality questionnaires and underwent [(18)F]altanserin positron emission tomography. We found a significant interaction between neuroticism and familial risk in predicting the frontolimbic 5-HT(2A) receptor binding (p=0.026) in an analysis adjusting for age and body mass index. Within the high-risk group only, neuroticism and frontolimbic 5-HT(2A) receptor binding was positively associated (p=0.0037). In conclusion, our data indicate that familial risk and neuroticism interact in their relation to frontolimbic 5-HT(2A) receptor binding. These findings point at a plausible neurobiological link between genetic and personality risk factors and vulnerability to developing mood disorders. It contributes to our understanding of why some people at high risk develop mood disorders while others do not. We speculate that an increased stress reactivity in individuals at high familial risk for mood disorders might enhance the effect of neuroticism in shaping the impact of potential environmental stress and thereby influence serotonergic neurotransmission.

Citing Articles

Locus coeruleus catecholamines link neuroticism and vulnerability to tau pathology in aging.

Parent J, Ciampa C, Harrison T, Adams J, Zhuang K, Betts M Neuroimage. 2022; 263:119658.

PMID: 36191755 PMC: 10060440. DOI: 10.1016/j.neuroimage.2022.119658.


Decreases in State and Trait Anxiety Post-psilocybin: A Naturalistic, Observational Study Among Retreat Attendees.

Kiraga M, Kuypers K, Uthaug M, Ramaekers J, Mason N Front Psychiatry. 2022; 13:883869.

PMID: 35873251 PMC: 9300865. DOI: 10.3389/fpsyt.2022.883869.


Common HTR2A variants and 5-HTTLPR are not associated with human in vivo serotonin 2A receptor levels.

Spies M, Nasser A, Ozenne B, Jensen P, Knudsen G, Fisher P Hum Brain Mapp. 2020; 41(16):4518-4528.

PMID: 32697408 PMC: 7555071. DOI: 10.1002/hbm.25138.


Pharmacological sex hormone manipulation as a risk model for depression.

Frokjaer V J Neurosci Res. 2020; 98(7):1283-1292.

PMID: 32399989 PMC: 7383584. DOI: 10.1002/jnr.24632.


Trait Openness and serotonin 2A receptors in healthy volunteers: A positron emission tomography study.

Stenbaek D, Kristiansen S, Burmester D, Korsbak Madsen M, Frokjaer V, Knudsen G Hum Brain Mapp. 2019; 40(7):2117-2124.

PMID: 30633430 PMC: 6865516. DOI: 10.1002/hbm.24511.


References
1.
Kajantie E . Fetal origins of stress-related adult disease. Ann N Y Acad Sci. 2006; 1083:11-27. DOI: 10.1196/annals.1367.026. View

2.
Quarantelli M, Berkouk K, Prinster A, Landeau B, Svarer C, Balkay L . Integrated software for the analysis of brain PET/SPECT studies with partial-volume-effect correction. J Nucl Med. 2004; 45(2):192-201. View

3.
Caspi A, Sugden K, Moffitt T, Taylor A, Craig I, Harrington H . Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science. 2003; 301(5631):386-9. DOI: 10.1126/science.1083968. View

4.
Fanous A, Gardner C, Prescott C, Cancro R, Kendler K . Neuroticism, major depression and gender: a population-based twin study. Psychol Med. 2002; 32(4):719-28. DOI: 10.1017/s003329170200541x. View

5.
Links J, Prince J, Bryan R, McVeigh E, Leal J, Davatzikos C . Measurement of radiotracer concentration in brain gray matter using positron emission tomography: MRI-based correction for partial volume effects. J Cereb Blood Flow Metab. 1992; 12(4):571-83. DOI: 10.1038/jcbfm.1992.81. View